Davis Andrew S.'s Form 4 filing
Silk Road Medical Inc (SILK) · filed Aug 3, 2021
- Accession no.
- 0001593968-21-001927
- Filed
- Aug 3, 2021
- Trade date
- Aug 2, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $320.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Andrew S.CIK 0001770191 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Common Stock | MOption exerciseAcquired | +5,523 | $4.73 | +$26,123.79 | 37,115 | Direct | |
| Aug 2, 2021 | Common Stock | SSaleDisposed | −5,523 | $50.75F2 | −$280,292.25 | 31,592 | Direct | |
| Aug 2, 2021 | Common Stock | MOption exerciseAcquired | +801 | $4.73 | +$3,788.73 | 32,393 | Direct | |
| Aug 2, 2021 | Common Stock | SSaleDisposed | −801 | $50.75F2 | −$40,650.75 | 31,592 | Direct | |
| Aug 2, 2021 | Common Stock | AGrant or awardAcquired | +38,820 | $0.00 | $0 | 70,412 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Common Stock | MOption exerciseDisposed | −5,523 | $0.00 | $0 | 67,745 | Direct | |
| Aug 2, 2021 | Common Stock | MOption exerciseDisposed | −801 | $0.00 | $0 | 35,310 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at price ranging from $48.70 to $52.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.